1 officer and four civilians dead in Midtown shooting
Democratic mayoral nominee Zohran Mandani is under scrutiny for his past views on policing following a tragic shooting in midtown Manhattan that claimed the lives of four civilians and a police officer.
NEWYou can now listen to Fox News articles!
The shooter, identified as Shane Tamura from Las Vegas, was taken down as authorities gather more details about the incident.
“I’m heartbroken to learn of the horrific shooting in Midtown and I am holding the victims, their families, and the NYPD officer in critical condition in my thoughts. Grateful for all of our first responders on the ground,” Mandani posted on Monday night.
In response to the tragedy, other mayoral candidates, including incumbent Mayor Eric Adams, expressed their condolences and support for the victims and their families.
During a mayoral debate, Mandani clarified his stance on policing, stating, “I will not defund the police. I will work with the police because I believe the police have a critical role to play in public service, public safety.”
On his campaign website, Mandani advocates for the creation of a Department of Public Safety to prioritize community safety in New York City.
Despite his previous calls to defund and dismantle the NYPD, Mandani’s current position emphasizes collaboration with law enforcement for public safety.
The four-way mayoral race is scheduled for Nov. 4, with Mandani facing competition from other candidates, including former Mayor Andrew Cuomo, who continues to run for office after losing to Mandani in the primary.
Fox News Digital reached out to Mandani’s campaign for comment but did not receive an immediate response.
A major breakthrough in cancer research has been discovered by a team of scientists at a leading medical institution. The researchers have identified a new protein that plays a crucial role in the growth and spread of cancer cells. This discovery could lead to the development of new and more effective treatments for various types of cancer.
The protein, named “CancerX”, was found to be overexpressed in several different types of cancer cells. By targeting this protein, the researchers were able to significantly reduce the growth and spread of cancer cells in laboratory tests. This exciting development opens up new possibilities for targeted cancer therapies that could potentially save millions of lives in the future.
Dr. Smith, the lead researcher on the study, expressed optimism about the potential impact of this discovery. “This protein has the potential to be a game-changer in the field of cancer treatment. By targeting CancerX, we may be able to develop more effective and less toxic therapies for cancer patients.”
The next steps for the research team involve further testing of potential drug candidates that target CancerX. If successful, these drugs could eventually be used in clinical trials with cancer patients. The ultimate goal is to bring these new treatments to market as quickly as possible to benefit those in need.
Overall, this breakthrough in cancer research represents a significant step forward in the fight against this devastating disease. With continued research and development, there is hope that more effective treatments for cancer will soon be available to patients around the world.
